Leber Congenital Amaurosis 5 (LCA5) Peptide
Quick Overview for Leber Congenital Amaurosis 5 (LCA5) Peptide (ABIN979227)
Target
Origin
Source
Application
-
-
Characteristics
- This is a synthetic peptide designed for use in combination with anti-LCA5 antibody (Catalog #: ARP53410_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
Purification
- Purified
-
-
-
-
Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
Concentration
- 1 mg/mL
-
Buffer
- Final peptide concentration is 1 mg/mL in PBS.
-
Handling Advice
- Avoid repeated freeze-thaw cycles.
-
Storage
- -20 °C
-
Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- LCA5 (Leber Congenital Amaurosis 5 (LCA5))
-
Background
-
LCA5 is a protein that is thought to be involved in centrosomal or ciliary functions. Mutations in this gene cause Leber congenital amaurosis type V. This gene encodes a protein that is thought to be involved in centrosomal or ciliary functions. Mutations in this gene cause Leber congenital amaurosis type V. Alternative splicing results in two transcript variants.
Alias Symbols: C6orf152
Protein Size: 697 -
Molecular Weight
- 80 kDa
-
Gene ID
- 167691
-
NCBI Accession
- NM_181714, NP_859065
-
UniProt
- Q86VQ0
Target
-